NCT00685568 2018-11-07
Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis
M.D. Anderson Cancer Center
Phase 1 Completed
Clinical Trials
9 trialsNCT00081848 2017-07-02
Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00085163 2015-10-20
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00005094 2013-04-12
Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
National Cancer Institute (NCI)
Phase 3 Completed
NCT00258232 2013-04-08
Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00084721 2013-01-31
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT00466505 2012-12-19
Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT00064181 2012-09-24
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00473980 2012-04-02
Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients
Göteborg University
Phase 4 Completed